Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

2005
2025

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2012 1
2021 3
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial.
Borobia AM, Carcas AJ, Pérez-Olmeda M, Castaño L, Bertran MJ, García-Pérez J, Campins M, Portolés A, González-Pérez M, García Morales MT, Arana-Arri E, Aldea M, Díez-Fuertes F, Fuentes I, Ascaso A, Lora D, Imaz-Ayo N, Barón-Mira LE, Agustí A, Pérez-Ingidua C, Gómez de la Cámara A, Arribas JR, Ochando J, Alcamí J, Belda-Iniesta C, Frías J; CombiVacS Study Group. Borobia AM, et al. Lancet. 2021 Jul 10;398(10295):121-130. doi: 10.1016/S0140-6736(21)01420-3. Epub 2021 Jun 25. Lancet. 2021. PMID: 34181880 Free PMC article. Clinical Trial.
Cerebral and spinal cord subdural hematomas.
Lamela A, Lynch KM, Muriello MA, Ho DT. Lamela A, et al. Arch Neurol. 2012 Apr;69(4):543. doi: 10.1001/archneurol.2011.2220. Arch Neurol. 2012. PMID: 22491203 No abstract available.